Results 51 to 60 of about 824 (161)

Diverse fungi associated with partial irregular heartwood of Dalbergia odorifera [PDF]

open access: yesScientific Reports, 2015
AbstractDalbergia odorifera T. Chen is a medium-sized evergreen tree that produces purple-brown heartwood called JiangXiang in traditional Chinese medicine, the formation process of which takes several decades. In this study, a standard culture method was used to isolate fungi from the wounded and normal stems of D.
Sisheng Sun   +3 more
openaire   +2 more sources

A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action. [PDF]

open access: yesPLoS ONE, 2014
Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases.
Xiang Li   +8 more
doaj   +1 more source

First report of cauliflower anthracnose caused by Colletotrichum gigasporum in India

open access: yes, 2022
New Disease Reports, Volume 46, Issue 1, July 2022.
Tejbhan Saini   +2 more
wiley   +1 more source

Anti-inflammatory flavonoid derivatives from the heartwood of Dalbergia odorifera T. Chen

open access: yes, 2022
Two pairs of flavonoid enantiomers (1a/1b and 2a/2b) together with three known analogues (3–5) were isolated from the heartwood of Dalbergia odorifera T. Chen. Their structures were elucidated by extensive spectroscopic analysis (1 D and 2 D NMR, UV, IR,
Rong-Ye Wang (13038022)   +10 more
core   +1 more source

A Review on the Medicinal Plant Dalbergia odorifera Species: Phytochemistry and Biological Activity. [PDF]

open access: yesEvid Based Complement Alternat Med, 2017
The crucial medicinal plant Dalbergia odorifera T. Chen species belongs to genus Dalbergia, with interesting secondary metabolites, consisting of main classes of flavonoid, phenol, and sesquiterpene derivatives, as well as several arylbenzofurans, quinones, and fatty acids.
Ninh The S.
europepmc   +4 more sources

Tongxinluo for the Secondary Prevention of Atherosclerotic Disease: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials

open access: yesBrain and Behavior, Volume 16, Issue 3, March 2026.
This systematic review and meta‐analysis aims to evaluate the efficacy of tongxinluo in the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). In summary, among patients with ASCVD, tongxinluo was associated with a trend toward a reduced incidence of stroke and a 28% lower risk of major adverse cardiovascular events (MACE), which ...
Yanyan Feng   +3 more
wiley   +1 more source

Avaliação da potencial atividade antimicrobiana de produtos de origem natural: estudo bioguiado de Dalbergia ecastaphyllum L. Taub [PDF]

open access: yes, 2012
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2011A pesquisa de novas substâncias com potencial antimicrobiano possui grande relevância científica, pois
Aresi, Cassandra
core  

Effects of Waterlogging Stress on the Neighboring Relationships between Cleistocalyx operculatus (Roxb.) Merr. and Dalbergia odorifera T. Chen Saplings

open access: yes, 2023
Neighboring relationships among plants have been extensively reported, but little is known about the effect of waterlogging. In this study, Cleistocalyx operculatus (Roxb.) Merr. and Dalbergia odorifera T.
Luyao Guo   +5 more
core   +1 more source

Latifolin protects against myocardial infarction by alleviating myocardial inflammatory via the HIF-1α/NF-κB/IL-6 pathway

open access: yesPharmaceutical Biology, 2020
Context The Traditional Chinese herb medicine Dalbergia odorifera T. Chen (Fabaceae), exerted a protective effect on myocardial ischaemia. Latifolin is a neoflavonoid extracted from Dalbergia odorifera.
Xiao-Xiao Lai   +6 more
doaj   +1 more source

Integrating Traditional Wisdom With Modern Science: Ginsenosides as Antiheart Failure Agents

open access: yesCardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Heart failure (HF), as the terminal stage of various cardiovascular diseases, remains a global health challenge with persistently high morbidity and mortality rates. Although current therapies—including angiotensin receptor–neprilysin inhibitors, sodium‐glucose cotransporter‐2 inhibitors, and cardiac resynchronization therapy—have improved outcomes ...
Li Zhou   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy